SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFN14A - Definitive proxy statement filed by non-management:
SEC Accession No. 0001193125-11-273900
Filing Date
2011-10-18
Accepted
2011-10-18 17:04:24
Documents
5
Period of Report
2011-10-21
Effectiveness Date
2011-10-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d234844ddefn14a.htm DEFN14A 337287
2 GRAPHIC g234844g07x85.jpg GRAPHIC 5184
3 GRAPHIC g234844g13n93.jpg GRAPHIC 712
4 GRAPHIC g234844g23d94.jpg GRAPHIC 7916
5 GRAPHIC g234844g33y06.jpg GRAPHIC 664
  Complete submission text file 0001193125-11-273900.txt   359439
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFN14A | Act: 34 | File No.: 001-10865 | Film No.: 111146231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017 2129831310
MSMB Capital Management LLC (Filed by) CIK: 0001530053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFN14A